Histamine H3 receptor modulates nociception in a rat model of cholestasis

Pharmacology Biochemistry and Behavior

Volumn 96, Issue 3, 2010, Pages 312-316

  Hasanein, Parisa ^a  

^a BU ALI SINA UNIVERSITY   (Iran)

Author keywords

Antinociception; Cholestasis; Histamine; Immepip; Rats; Thioperamide

Indexed keywords

HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR AGONIST; IMMEPIP; NALOXONE; THIOPERAMIDE; UNCLASSIFIED DRUG; 4-(1H-IMIDAZOL-4-YLMETHYL)PIPERIDINE; HISTAMINE AGONIST; HISTAMINE H3 RECEPTOR ANTAGONIST; IMIDAZOLE DERIVATIVE; NARCOTIC ANTAGONIST; PIPERIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BILE DUCT LIGATION; CHOLESTASIS; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; MALE; MOTOR COORDINATION; MOTOR PERFORMANCE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; ROTAROD TEST; TAIL FLICK TEST; ANIMAL; ANIMAL BEHAVIOR; BILE DUCT; BODY EQUILIBRIUM; COMPLICATION; DRUG EFFECTS; PAIN; PAIN MEASUREMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; REACTION TIME; WISTAR RAT;

ANIMALS; BEHAVIOR, ANIMAL; BILE DUCTS; CHOLESTASIS; HISTAMINE AGONISTS; HISTAMINE H3 ANTAGONISTS; IMIDAZOLES; MALE; NALOXONE; NARCOTIC ANTAGONISTS; PAIN; PAIN MEASUREMENT; PIPERIDINES; POSTURAL BALANCE; RATS; RATS, WISTAR; REACTION TIME; RECEPTORS, HISTAMINE H3;

ANIMALIA; RATTUS;

EID: 77954758022     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.05.023     Document Type: Article

References (44)

1. 3) of histamine receptor. Nature 1983, 302:832-837.
2. 3-receptors. Nature 1987, 327:117-123.
3. Bergasa N.V., Rothman R.B., Vergalla J., Xu H., Swain M.G., Jones E.A. Central mu-opioid receptors are down-regulated in a rat model of cholestasis. J Hepatol 1992, 15:220-224.
4. Bergasa N.V., Alling D.W., Vergalla J., Jones E.A. Cholestasis in the male rat is associated with naloxone-reversible antinociception. J Hepatol 1994, 20:85-90.
5. 3 receptors inhibits mechanical nociception. Eur J Pharmacol 2003, 470(3):139-147.
6. 3 receptors. J Pain 2005, 6:193-200.
7. 3 receptors in rodent skin, dorsal root ganglia, superior cervical ganglia, and spinal cord: potential antinociceptive targets. Pain 2007, 129(1-2):76-92.
8. 3 receptors inhibits formalin-induced inflammation and nociception, respectively. Pharmacol Biochem Behav 2007, 88(1):122-129.
9. 4 receptor as a new therapeutic target for inflammation. Trends Pharmacol Sci 2005, 26:462-469.
10. Dehpour A.R., Sadeghipour H.R., Nowroozi A., Akbarloo N. The effect of the serotonergic system on opioid withdrawal-like syndrome in a mouse model of cholestasis. Hum Psychopharmacol 2000, 15:423-428.
11. Farzin D., Asghari L., Nowrouzi M. Rodent antinociception following acute treatment with different histamine receptor agonists and antagonists. Pharmacol Biochem Behav 2002, 72(3):751-760.
12. Girard P., Pansart Y., Coppé M.C., Verniers D., Gillardin J.M. Role of the histamine system in nefopam-induced antinociception in mice. Eur J Pharmacol 2004, 503:63-69.
13. Gogas K.R., Hough L.B., Eberle N.B., Lyon R.A., Glick S.D., Ward S.J., et al. A role for histamine and H2-receptors in opioid antinociception. J Pharmacol Exp Ther 1989, 250:476-484.
14. Hasanein P., Parviz M., Keshavarz M., Javanmardi K., Allahtavakoli M., Ghaseminejad M. Modulation of cholestasis-induced antinociception in rats by two NMDA receptor antagonists: MK-801 and magnesium sulfate. Eur J Pharmacol 2007, 554:123-127.
15. Hasanein P., Javanmardi K. A potent and selective inhibitor of endocannabinoid uptake, UCM707, potentiates antinociception induced by cholestasis. Fundam Clin Pharmacol 2008, 22:517-522.
16. Hasanein P. The endocannabinoid transport inhibitor AM404 modulates nociception in cholestasis. Neurosci Lett 2009, 462(3):230-234.
17. 4 ligands. Mini-Rev Med Chem 2004, 4:993-1000.
18. Javanmardi K., Parviz M., Sadr S.S., Keshavarz M., Minaii B., Dehpour A.R. Involvement of N-methyl-d-aspartate receptors and nitric oxide in the rostral ventromedial medulla in modulating morphine pain-inhibitory signals from the periaqueductal grey matter in rats. Clin Exp Pharmacol Physiol 2005, 32:585-589.
19. Lamberti C., Bartolini A., Ghelardini C., Malmberg-Aiello P. Investigation into the role of histamine receptors in rodent antinociception. Pharmacol Biochem Behav 1996, 53(3):567-574.
20. Malmberg-Aiello P., Lamberti C., Ghelardini C., Giotti A., Bartolini A. Role of histamine in rodent antinociception. Br J Pharmacol 1994, 111:1269-1279.
21. Malmberg-Aiello P., Lamberti C., Ipponi A., Bartolini A., Schunack W. Evidence for hypernociception induction following histamine H1 receptor activation in rodents. Life Sci 1998, 63:463-476.
22. Mobarakeh J.I., Sakurada S., Katsuyama S., Kutsuwa M., Kuramasu A., Lin Z., et al. Role of histamine H (1) receptor in pain perception: a study of the receptor gene knockout mice. Eur J Pharmacol 2000, 391:81-89.
23. Mobarakeh J.I., Takahashi K., Sakurada S., Nishino S., Watanabe H., Kato M., et al. Enhanced antinociception by intracerebroventricularly administered orexin A in histamine H1 or H2 receptor gene knockout mice. Pain 2005, 118:254-262.
24. Mobarakeh J.I., Takahashi K., Sakurada S., Kuramasu A., Yanai K. Enhanced antinociceptive effects of morphine in histamine H2 receptor gene knockout mice. Neuropharmacol 2006, 51:612-622.
25. 3 receptor gene knockout mice. Neuropharmacol 2009, 57(4):409-414.
26. Nalwalk J.W., Hough L.B. Importance of histamine H2 receptors in restraint-morphine interactions. Life Sci 1995, 57:PL153-PL158.
27. Nelson L., Vergnolle N., D'Mello C., Chapman K., Le T., Swain M.G. Endogenous opioid-mediated antinociception in cholestatic mice is peripherally, not centrally, mediated. J Hepatol 2006, 44:1141-1149.
28. Oluyomi A.O., Hart S.L. Involvement of histamine in naloxone-resistant and naloxone-sensitive models of swim stress-induced antinociception in the mouse. Neuropharmacol 1991, 30:1021-1027.
29. Onodera K., Yamatodani A., Watanabe T., Wada H. Neuropharmacology of the histaminergic neuron system in the brain and its relationship with behavioral disorders. Prog Neurobiol 1994, 42:685-702.
30. 3-receptor ligands. Agents Actions 1994, 41. Spec No:C62-3.
31. Pillot C., Heron A., Cochois V., Tardivel-Lacombe J., Ligneau X., Schwartz J.C., et al. A detailed mapping of the histamine H(3) receptor and its gene transcripts in rat brain. Neuroscience 2002, 114:173-193.
32. Rastegar H., Homayoun H., Afifi M., Rezayat M., Dehpour A.R. Modulation of cholestasis-induced antinociception by CCK receptor agonists and antagonists. Eur Neuropsychopharmacol 2002, 12:111-118.
33. 3 receptor agonist prodrug. J Pharmacol Exp Ther 1997, 281:1085-1094.
34. Schwartz J.C., Arrang J.M., Garbarg M., Korner M. Properties and roles of the three subclasses of histamine receptors in brain. J Exp Biol 1986, 124:203-224.
35. Schwartz J.C., Arrang J.M., Garbarg M., Pollard H., Ruat M. Histaminergic transmission in the mammalian brain. Physiol Rev 1991, 71:1-51.
36. Swain M.G., Rothman R.B., Xu H., Vergalla J., Bergasa N.V., Jones E.A. Endogenous opioids accumulate in plasma in a rat model of acute cholestasis. Gastroenterol 1992, 103:630-635.
37. Swain M.G., MacArthur L., Vergalla J., Jones E.A. Adrenal secretion of BAM-22P, a potent opioid peptide, is enhanced in rats with acute cholestasis. Am J Physiol 1994, 266:G201-G205.
38. Suh H.W., Song D.K., Choi Y.S., Kim Y.H. Effects of intrathecally injected histamine receptor antagonists on the antinociception induced by morphine, beta-endorphin, and U50, 488H administered intrathecally in the mouse. Neuropeptides 1996, 30(5):485-490.
39. Suh H.W., Chung K.M., Kim Y.H., Huh S.O., Song D.K. Effects of histamine receptor antagonists injected intrathecally on antinociception induced by opioids administered intracerebroventricularly in the mouse. Neuropeptides 1999, 33(2):121-129.
40. Suzuki T., Takamori K., Takahashi Y., Narita M., Misawa M., Onodera K. The differential effects of histamine receptor antagonists on morphine- and U-50, 488H-induced antinociception in the mouse. Life Sci 1994, 54(3):203-211.
41. Thornton J.R., Losowsky M.S. Opioid peptides and primary biliary cirrhosis. BMJ 1988, 297:1501-1504.
42. Thornton J.R., Losowsky M.S. Methionine enkephalin is increased in plasma in acute liver disease and is present in bile and urine. J Hepatol 1989, 8:53-59.
43. 4 receptors as novel drug targets. Expert Opin Investig Drugs 2009, 18:1519-1531.
44. Yanai K., Mobarakeh J.I., Kuramasu A., Sakurada S. Roles of histamine receptors in pain perception: a study using receptors gene knockout mice. Nippon Yakurigaku Zasshi 2003, 122:391-399.